| Ligand name |
Abbreviated name |
Synonyms |
| A |
Back to top |
|
A-71378
|
|
A71378
|
|
A-71623
|
|
A71623,
A 71623,
L-Phenylalaninamide
|
|
A-71915
|
|
A71915,
A 71915,
(Arg6,?-cyclohexyl-Ala8,D-Tic16,Arg17,Cys18)-Atrial Natriuretic Factor (6-18) amide (mouse, rabbit, rat),
([Arg6, Cha8]ANP6-15-d-Tic-Arg-Cys-NH2,
H-3048
|
|
A8Δ71-73
|
|
|
|
abarelix
|
|
Plenaxis,
PPI 149,
R 3827
|
|
ABS-201
|
|
ABS201
|
|
ABS212
|
|
ABS 212
|
|
Abz-Ser-Pro-Tyr(NO2)-OH
|
|
o-aminobenzoyl-Ser-Pro-Tyr(NO2)-OH
|
|
AC-178,335
|
|
AC 178335
|
|
AC187
|
|
AC 187,
acetyl-(Asn30,Tyr32)-calcitonin8-32,
salmon calcitonin (8-32) reduced
|
|
Ac-c[Cys-Glu-His-D-Phe-Arg-Trp-D-Cys]-Pro-Pro-Lys-Asp-NH2
|
|
|
|
[Ac-D-2Nal1,D4CPA2,D-3Pal3,6,Leu8, D-Ala10]GnRH-II
|
|
|
|
Ac-GRP-(20-26)-methylester
|
|
N-acetyl-GRP-(20-26)-ethylester
|
|
[Ac-His1]PACAP-27
|
|
[Ac-His1]pituitary adenylate cyclase activating polypeptide-27
|
|
Ac-hMCH-(6-16)-NH2
|
|
hAc-MCH(6-16)-NH2,
human Ac-MCH6-16-NH2
|
|
Ac-Lys-[MeAla6,Leu8,des-Arg9]bradykinin
|
|
Ac-[MeAla6,Leu8,des-Arg9]kallidin,
N-acetylated-[Lys,MeAla6,Leu8,des-Arg9]bradykinin
|
|
AcPhe-Orn-Pro-D-Cha-Trp-Arg
|
|
AcF[OP-D-Cha-Wr]
|
|
Ac-RYYRIK-NH2
|
|
|
|
Ac-RYYRWK-NH2
|
|
|
|
ACTH-(11-24)
|
|
ACTH (11-24),
adrenocorticotropic hormone (11-24)
|
|
ACTH-(1-24)
|
|
ACTH (1-24),
adrenocorticotropic hormone (1-24)
|
[125I]ACTH-(1–24)
|
|
[125I]-ACTH(1–24),
[125I]-adrenocorticotropin(1–24)
|
|
[Ac-Tyr1, D-Arg2]GHRH-(1-29)-NH2 (human)
|
|
|
|
AF12198
|
|
AF 12198
|
|
AFT-II
|
|
neurotoxin-2,
Toxin AFII,
Toxin AFT-II
|
|
ω-agatoxin IIIA
|
|
omega-Aga-IIIA,
Omega-agatoxin-Aa3a
|
|
ω-agatoxin IVA
|
|
omega-Aga-IVA,
Omega-agatoxin-Aa4a
|
|
ω-agatoxin IVB
|
|
Omega-agatoxin-Aa4b
|
|
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-34)-NH2
|
|
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-hPTH 1-34-NH2,
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-34-NH2 (human),
M-PTH(1–34)
|
|
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-21)-NH2 (human)
|
|
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]hPTH-(1-21)-NH2,
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-21-NH2 (human),
M-PTH(1–21)
|
|
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-28)-NH2 (human)
|
|
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-hPTH 1-28-NH2,
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-28-NH2 (human),
M-PTH(1–28)
|
|
[Ala1,12,Aib3,Gln10,hArg11,Trp14]PTH-(1-14)-NH2
|
|
[Ala1,12,Aib3,Gln10,hArg11,Trp14]-hPTH 1-14-NH2,
[Ala1,12,Aib3,Gln10,hArg11,Trp14]-PTH 1-14-NH2 (human),
M-PTH(1–14)
|
|
[Ala31,Aib32]NPY
|
|
|
|
[Ala31,Aib32]NPY (pig)
|
|
|
|
[Ala11, D-Leu15]orexin-B
|
|
|
|
[Ala1,3,11,15]ET-1
|
|
[Ala1,3,11,15]endothelin-1
|
[125I][Ala1,3,11,15]ET-1
|
|
[125I]-[Ala1,3,11,15]endothelin-1,
[125I][Ala1,3,11,15]endothelin-1
|
|
[βAla8]neurokinin A-(4-10)
|
|
[βAla8]neurokinin A (4-10)
|
|
[Ala11,22,28]VIP
|
|
[Ala11,22,28]vasoactive intestinal peptide
|
|
ALX40-4C
|
|
ALX 40-4C,
N-alpha-acetyl-nona-D-arginine amide acetate
|
|
AM3
|
|
DOTA-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-D-Trp-Lys-Thr-Cys)
|
|
amanitin
|
|
α-amanitin
|
|
AM-(22-52) (human)
|
|
AM (22-52),
human adrenomedullin (22-52)
|
|
AM-(11-50) (rat)
|
|
AM (11-50),
rat adrenomedullin (11-50)
|
|
AM-(20-50) (rat)
|
|
rat adrenomedullin (20-50)
|
[125I]AM (rat)
|
|
[125I]-adrenomedullin,
[125I]-AM
|
|
analog 3
|
|
|
|
analog 30
|
|
|
|
analog 31
|
|
|
|
anantin
|
|
|
[125I]angiotensin-(1-7)
|
|
[125I]ang-(1-7)
|
[125I]ANP
|
|
[125I]-ANP
|
|
antarelix
|
|
D-23234,
EP 24332,
Teverelix
|
|
antide
|
|
D 21074,
ORF 23541
|
|
antisauvagine
|
|
antisauvagine-30,
[dPhe11,His12]Svg(11–40)
|
[125I]antisauvagine
|
|
|
|
AP811
|
|
AP 811,
AP-811,
(s)-N2-([4-{(2-naphthalenylcarbonyl)amino}phenyl]acetyl)-l-arginyl-l-isoleucyl-l-α-aspartyl-N-(2-methylbutyl)-l-argininamide
|
|
apamin
|
|
|
[125I]apelin-13
|
|
|
|
apelin-13(F13A)
|
|
|
|
APETx-1
|
|
Toxin APETx1
|
|
APETx2
|
|
|
|
[Arg16]chicken secretin
|
|
[R16]chicken secretin
|
|
[Arg14Lys15]N/OFQ
|
|
[Arg14Lys15]nociceptin,
[Arg14Lys15]nociceptin/orphanin FQ,
[Arg14Lys15]orphanin FQ
|
|
[Arg19]PTH-(1-34) (human)
|
|
[Arg19]-PTH 1-34 (human)
|
|
ARL-15849
|
|
ARL 15849XX,
AR-R 15849,
FPL 15849
|
|
ASIP [90-132 (L89Y)]
|
|
agouti-signaling protein [90-132 (L89Y)],
agouti-signaling protein[90-132 (L89Y)]
|
|
astressin
|
|
|
[125I]astressin
|
|
|
|
[Asu7,23']β-ANP-(7-28)
|
|
[Asu7,23']-β-ANP7-28
|
|
atosiban
|
|
d[D-Tyr(Et)2,Thr4,Orn8]vasotocin,
d[D-Tyr(Et)2,Thr4]OVT,
ORF22164,
RWJ 22164
|
|
ATX-II
|
|
anemonia viridis toxin 2,
As2,
Av2,
neurotoxin 2,
Sea anemone toxin II (Anemonia sulcata),
Toxin ATX-II,
Toxin II
|
|
Ava3
|
|
|
|
Ava5
|
|
|
|
[Ava9,10,Ava14,15]-Ac-hMCH6-16-NH2
|
|
compound 30 [PMID:12009900]
|
[3H]AVP
|
|
[3H]arginine vasopressin
|
|
AVT
|
|
arginine vasotocin,
argiprestocin,
[Arg8]vasotocin
|
|
AYPGKF-NH2
|
|
AY-NH2
|
| |
| B |
Back to top |
|
B-10356
|
|
|
|
B-9430
|
|
B 9430,
trans-4-hydroxy-L-proline,{alpha}-2-indanylglycine,octahydroindole-2-carboxylic acid
|
|
B-9858
|
|
B 9858,
Lys-Lys-[Hyp3, Igl5, D-Igl7, Oic8]des-Arg9-BK
|
|
B-9958
|
|
B9958,
des-Arg(9)-BK,,
des-arginine(9)-bradykinin,
Lys-Lys-[Hyp(3), CpG(5), D-Tic(7), CpG(8)]des-Arg(9)-BK,
|
|
BAM8-22
|
|
8-22-BAM,
BAM-15
|
|
BASS antagonist
|
|
BASS antagonist Analog 4
|
|
BAY 55-9837
|
|
|
[125I]BAY 55-9837
|
|
|
|
BBL-454
|
|
BBL454,
BBL 454
|
|
BC-254
|
|
BC 254
|
|
BC264
|
|
|
|
BC-264
|
|
BC264,
BC 264
|
|
Bc-III
|
|
major neurotoxin BcIII
|
[125I]BDNF
|
|
[125I]-BDNF,
[125I]-brain-derived neurotrophic factor
|
|
BeKm-1
|
|
neurotoxin BeKm-1,
potassium channel toxin γ-KTx 2.1
|
|
BgK
|
|
Potassium channel toxin Bgk
|
[125I]BgK (W5Y / Y26F)
|
|
|
[125I]BH-AMY (rat, mouse)
|
|
[125I]-BH-AMY,
[125I]-Bolton Hunter amylin
|
[125I]BH-NMB
|
|
[125I]-BH-NMB,
[125I]-Bolton Hunter neuromedin B
|
[125I]BH-[Sar9,Met(O2)11]SP
|
|
[125I]-BH-[Sar9,Met(O2)11]SP,
[125I]-Bolton Hunter-[Sar9,Met(O2)11]substance P
|
[3H]BH-[Sar9,Met(O2)11]SP
|
|
[3H]-BH-[Sar9,Met(O2)11]SP,
[3H]-Bolton Hunter-[Sar9,Met(O2)11]substance P
|
|
BIM 23023
|
|
|
|
BIM 23027
|
|
BIM23027
|
|
BIM 23030
|
|
|
|
BIM 23034
|
|
DC 13-212
|
|
BIM 23050
|
|
BIM-23050
|
|
BIM 23052
|
|
BIM23052,
BIM-23052,
DC-(23-99)
|
|
BIM 23056
|
|
|
|
BIM 23058
|
|
|
|
BIM 23059
|
|
|
|
BIM 23060
|
|
|
|
BIM 23066
|
|
|
|
BIM 23068
|
|
|
|
BIM 23127
|
|
|
|
BIM 23197
|
|
|
|
BIM 23268
|
|
BIM23268
|
|
BIM 23295
|
|
|
|
BIM 23313
|
|
|
|
BIM 23454
|
|
|
|
BIM 23627
|
|
H-5886,
MW 1164
|
|
BIM28011
|
|
BIM 28011,
[D-Ala2,Ala8,9,15,27,D-Arg29]hGHRH(1–29)NH2
|
|
BIM 28163
|
|
|
[125I]BIM23027
|
|
[125I]-BIM23027,
[125I]-BIM 23027
|
[3H]BK (human, mouse, rat)
|
|
[3H]-BK,
[3H]-bradykinin
|
|
BmP09
|
|
beta-toxin BmKAs1,
B. martensi Karsch toxin,
BmK activator of skeletal-muscle ryanodine receptor,
BmK AS-1,
toxin BmP09
|
|
BOC-ATE
|
|
|
|
BODIPY® TMR-NMU
|
|
|
|
bombesin
|
|
|
|
[Bpa1,Ile13]motilin (human)
|
|
|
[Bpa6,Tyr10]secretin-27 (rat)
|
|
|
|
BP-CCL3
|
|
BP-LD78α,
BP-MIP-1α,
photoactivatable macrophage inflammatory protein-1α
|
|
BQ123
|
|
BQ 123
|
|
BQ 3020
|
|
BQ3020
|
[125I]BQ3020
|
|
[125I]-BQ3020
|
[3H]BQ123
|
|
[3H]-BQ123,
[3H]cyc(DTrp-DAsp-Pro-DVal-Leu
|
|
B-R13/17K H2 relaxin
|
|
B13/17K H2 relaxin
|
|
α-bungarotoxin
|
|
|
[125I]α-bungarotoxin
|
|
|
[3H]α-bungarotoxin
|
|
|
|
buserelin
|
|
etilamide,
HOE 766,
HOE 766A,
ICI 123215,
receptal,
suprefact
|
[125I]buserelin
|
|
[125I]-buserelin
|
|
Bv8
|
|
Bombina variegata protein
|
|
[Bz-Phe6]U-II (human)
|
|
human [Bz-Phe6] urotensin-II
|
| |
| C |
Back to top |
|
C089
|
|
|
|
C3
|
|
|
|
C7
|
|
galanin(1-13)spantide
|
|
C5a hexapeptide analogue
|
|
Phe-Lys-Ala-dCha-Cha-dArg
|
[125I]C3a (human)
|
|
[125I]-C3a
|
[125I]C5a (human)
|
|
[125I]-C5a
|
|
calciseptine
|
|
|
|
cANF4-23
|
|
des[Gln18,Ser19,Gly20,Leu21,Gly22]ANP4ヨ23-NH2
|
|
[125I]cathepsin G (human)
|
|
[125I]cathepsin G
|
|
CCK-58
{Sp: Dog}
|
|
|
|
CCK-8 (desulphated)
|
|
des-CCK-8,
Desulfated CCK-8,
Desulfated cholecystokinin-8,
Desulfated sincalide
|
[3H]CCK-8 (human, mouse, rat)
|
|
[3H]-CCK-8
|
[125I]CCL17
|
|
[125I]TARC
|
[125I]CCL19
|
|
[125I]ELC
|
[125I]CCL2
|
|
[125I]MCAF,
[125I]MCP-1,
[125I]monocyte chemotactic protein-1
|
[125I]CCL20
|
|
[125I]LARC,
[125I]MIP-3α
|
[125I]CCL21
|
|
[125I]SLC
|
[125I]CCL25
|
|
[125I]TECK
|
[125I]CCL27
|
|
[125I]CTACK
|
[125I]CCL11 (human)
|
|
[125I]eotaxin
|
[125I]CCL16 (human)
|
|
[125I]LEC
|
[125I]CCL1 (human)
|
|
[125I]I-309,
[125I]P500,
[125I]TCA-3
|
[125I]CCL3 (human)
|
|
[125I]macrophage inflammatory protein-1α,
[125I]MIP-1α
|
[125I]CCL4 (human)
|
|
[125I]macrophage inflammatory protein-1β,
[125I]MIP-1β
|
[125I]CCL5 (human)
|
|
[125I]RANTES,
[125I]regulated upon activation normal T cell expressed and secreted
|
[125I]CCL7 (human)
|
|
[125I]MCP-3,
[125I]monocyte chemotactic protein-3
|
[125I]CCL8 (human)
|
|
[125I]MCP-2,
[125I]monocyte chemotactic protein-2
|
[125I]CCL1 (mouse)
|
|
|
|
CCL20-SEAP(His)6
|
|
LARC fused with secreted alkaline phosphatase,
LARC-SEAP(His)6,
MIP-3α fused with secreted alkaline phosphatase
|
|
cetrorelix
|
|
SB-075
|
[125I]cetrorelix
|
|
|
|
CGP 23996
|
|
CGP23996,
CGP-23996
|
|
CGP42112
|
|
CGP 42112,
CGP 42112A
|
[125I]CGP 23996
|
|
|
[125I]CGP42112
|
|
Cgp-42112A,
Cgp 42112B,
[125I]-CGP42112
|
|
α-CGRP-(8-37) (human)
|
|
α-CGRP (8-37) (human),
human α-calcitonin gene-related peptide (8-37)
|
[125I]αCGRP (human)
|
|
[125I]-αcalcitonin gene-related peptide,
[125I]-αCGRP
|
|
α-CGRP-(8-37) (rat)
|
|
α-CGRP (8-37) (rat),
rat α-calcitonin gene-related peptide (8-37)
|
|
CH 275
|
|
desAA1,2,5[D-Trp8,IAmp9]somatostatin-14
|
|
charybdotoxin
|
|
ChTX
|
|
charybdotoxin-GLU32 analog
|
|
ChTX-GLU32
|
|
chemerin C-terminal peptide
|
|
bioactive chemerin peptide,
chemerin 149–157,
chemerin-9
|
|
CHIPS
|
|
chemotaxis inhibitory protein of S. aureus
|
|
CHIPS-(28-149)
|
|
CHIPS28-149
|
[125I]CHIPS
|
|
[125I]chemotaxis inhibitory protein of S. aureus
|
|
[(CH2NH)4,5]secretin
|
|
[ψ4,5]secretin
|
[125I]chorionic gonadotropin (human)
|
[125I]CG (human)
|
[125I]-CG,
[125I]-chorionic gonadotropin
|
|
4-Cl-cinnamoyl-c[DCys-4Pal-DTrp-Orn-Val-Cys]-His-amide
|
|
|
[125I]CNP (human)
|
|
[125I]-CNP
|
|
C2-NPY (pig)
|
|
|
|
compound 2 [PMID:11375253]
|
|
|
|
conantokin-G
|
|
|
|
concanavalin A
|
|
|
|
α-conotoxin ArIB
|
|
|
|
α-conotoxin AuIB
|
|
|
|
ω-conotoxin CVIA
|
|
|
|
ω-conotoxin CVIB
|
|
|
|
ω-conotoxin CVIC
|
|
|
|
ω-conotoxin CVID
|
|
AM336,
AM-336,
CNSB004,
Leconotide
|
|
α-conotoxin GI
|
|
G1
|
|
α-conotoxin-GIC
|
|
|
|
μ-conotoxin GIIIA
|
|
G3.9,
Geographutoxin I,
GTx-I,
Myotoxin I
|
|
ω-conotoxin GVIA
|
|
|
|
α-conotoxin ImI
|
|
α-CTx ImI
|
|
α-conotoxin MI
|
|
|
|
α-conotoxin MII
|
|
|
[125I]α-conotoxin MII
|
|
|
|
α-conotoxin MII [H9A, L15A]
|
|
|
|
ω-conotoxin MVIIA
|
|
SNX-111,
ziconotide
|
|
ω-conotoxin MVIIC
|
|
SNX-230
|
|
ω-conotoxin MVIID
|
|
SNX-238
|
|
α-conotoxin PIA
|
|
|
|
μ-conotoxin PIIIA
|
|
μ-conotoxin P3.7
|
|
α-conotoxin PnIA
|
|
|
|
α-conotoxin RgIA
|
|
|
|
α-conotoxin TxIA
|
|
|
|
contulakin-G
|
|
CGX-1160
|
[125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP
|
|
[125I]-[cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP
|
|
CRF
{Sp: Sheep}
|
|
corticoliberin,
corticotropin-releasing factor,
corticotropin-releasing hormone (ovine),
endorpholiberin
|
[125I]CRF (ovine)
|
|
[125I]corticotropin
|
|
CTAP
|
|
|
[125I]CT (human)
|
|
[125I]-calcitonin (Human),
[125I]-CT (Human)
|
|
CTOP
|
|
CTOPA,
Ctop-NH2,
phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide
|
|
CTR-stimulating peptide
{Sp: Pig}
|
|
calcitonin-receptor stimulating peptide,
CRSP-1
|
|
CT-(8-32) (salmon)
|
|
CT (8-32) (salmon),
salmon calcitonin (8-32)
|
|
CT (salmon)
|
|
salmon calcitonin
|
[125I]CT (salmon)
|
|
[125I]-calcitonin (Salmon),
[125I]-CT (Salmon)
|
|
CXCL12-(1-17)
|
|
CXCL12, 1-17,
SDF-1, 1-17,
stromal cell-derived factor-1, N-terminal fragment
|
|
CXCL12-(1-9)
|
|
CXCL12, 1-9
|
[125I]CXCL1
|
|
[125I]GROα
|
[125I]CXCL10
|
|
[125I]IP-10
|
[125I]CXCL11
|
|
[125I]I-TAC
|
[125I]CXCL16
|
|
|
[125I]CXCL5
|
|
[125I]ENA-78
|
[125I]CXCL7
|
|
[125I]NAP-2
|
|
CXCL12-(1-9) dimer
|
|
CXCL12, 1-9 dimer,
stromal cell-derived factor-1, N-terminal fragment dimer
|
[125I]CXCL8 (human)
|
|
[125I]IL-8,
[125I]interleukin-8
|
[125I]CX3CL1 (human)
|
|
[125I]Fractalkine
|
|
Cy3B-NMU-8
|
|
|
|
cyclo(7-12) Des-AA1,2,5-[Glu7,D-Trp8,IAmp9,m-I-Tyr11,hhLys12]SRIF
|
|
|
|
cyclorelix
|
|
D-23620
|
|
cyclosporin A
|
|
ciclosporin,
cyclosporin,
cyclosporine,
cyclosporine A
|
|
cyclosporin H
|
|
|
|
[Cys(ACM)2,7]CGRP
|
|
[Cys(ACM)2,7]-calcitonin gene-related peptide,
Cys(Acm)2,7-h-αCGRP
|
|
[Cys(Et)2,7]α-CGRP (human)
|
|
[cys(Et)2,7]α-calcitonin gene-related peptide (human)
|
| |
| D |
Back to top |
|
D-23487
|
|
D 23487
|
|
D-24710
|
|
D 24710,
N-[3-(4-fluorophenyl)-propionyl]-D-Nal-Ser-N-methyl-Tyr-D-Lys(Nic)-Leu-Lys(iPr)-Pro-ethylamide
|
|
[D-Ala2]deltorphin I
|
|
|
|
[D-Ala2]deltorphin II
|
|
|
|
[D-Ala2,F5,Phe4]dynorphin-(1-13)-NH2
|
|
[D-Ala2,F5,Phe4]-dynorphin 1-13-NH2
|
|
[D-Ala2,F5,Phe4]dynorphin-(1-17)-NH2
|
|
[D-Ala2,F5,Phe4]-dynorphin 1-17-NH2
|
|
DAMGO
|
|
2-Ala-4-mephe-5-gly-enkephalin,
(2S)-2-amino-N-[(1R)-1-[[[(1S)-1-(2-hydroxyethylcarbamoyl)-2-phenyl-ethyl]-methyl-carbamoyl]methylcarbamoyl]ethyl]-3-(4-hydroxyphenyl)propanamide,
Ala(2)-mephe(4)-gly-ol(5) enkephalin,
DAGO,
Dagol,
glyol,
Tyr-DAla-Gly-[NMePhe]-NH(CH2)2
|
[3H]DAMGO
|
|
[3H]-DAMGO,
[tyrosyl 3,5-3H]DAMGO
|
|
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P
|
|
|
|
dAVP
|
|
[deamino-Cys1]AVP,
[deamino1]AVP,
deamino-vasopressin
|
|
DAVP
|
|
[D-Arg8]VP,
[D-Arg8]vasopressin
|
|
[D-Bpa5,Ile13]motilin (human)
|
|
|
|
DC 23-60
|
|
|
|
d[Cha4]AVP
|
|
[1-Deamino-4-Cyclohexylalanine]AVP,
[deamino-Cys1,Cha4]AVP
|
[3H]d[Cha4]AVP
|
|
[3H][1-Deamino-4-Cyclohexylalanine]AVP,
[3H][deamino-Cys1,Cha4]AVP
|
|
d[Cha4,Dab8]VP
|
|
[deamino-Cys1,Cha4,Dab8]vasopressin
|
|
d[Cha4]LVP
|
|
[1-Deamino-4-Cyclohexylalanine]LVP,
[deamino-Cys1,Cha4,Lys8]vasopressin
|
|
d(CH2)5[D-Ile2,Ile4,Ala-NH2]AVP
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Ala-NH2]AVP
|
|
d(CH2)5[D-Ile2,Ile4,Ala-NH29]AVP
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Ala-NH29]AVP,
Pmp[D-Ile2,Ile4,Ala-NH2]AVP
|
|
d(CH2)5[D-Ile2,Ile4]AVP
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4]AVP,
d(CH2)5[D-Ile2,Ile4]VP
|
|
d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP
|
[125I]d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP
|
|
[125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP
|
|
d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP
|
[125I]d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP
|
|
[125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP
|
[125I]d(CH2)5[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP
|
|
d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP
|
[125I]d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP
|
|
[125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP
|
|
d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP
|
|
des-Gly9-[β-mercapto-β,β-cyclopentamethylenepropionyl1,O-ET-Tyr2,Val4,Arg8]vasopressin,
dGTyr(Et)VAVP,
Mcp-tva-argipressin,
SK&F 101926,
SK&F 10196
|
|
d(CH2)5[Tyr(Me)2,Arg8]VP
|
|
|
|
d(CH2)5[Tyr(Me)2]AVP
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[O-Me-Tyr2,Arg8]vasopressin,
d(CH2)5[O-methyl-Tyr2]AVP,
Pmp[Tyr(Me)2]AVP,
SKF-100273
|
[3H]d(CH2)5[Tyr(Me)2]AVP
|
|
[3H]-d(CH2)5[Tyr(Me)2,Arg8]AVP
|
[125I]d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT
|
|
[125I]-d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT
|
|
d(CH2)5[Tyr(Me)2,Thr4]OVT
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2-Thr4]OVT,
β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4]OVT,
d(CH2)5[O-Me-Tyr2-The4-Orn8]vasotocin,
d(CH2)5[O-Me-Tyr2,Thr4]ornithine vasotocin,
d(CH2)5[O-Me-Tyr2,Thr4,Orn8]vasotocin
|
|
d(CH2)5[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT,
β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT,
d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3I,4N3)-NH29]vasotocin,
I-ZOTA
|
d(CH2)5[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT,
d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3125I,4N3)-NH29]vasotocin,
[125I]ZOTA
|
d(CH2)5[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT,
d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr(3125I)-NH29]vasotocin,
[125I]D-(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin,
[125I]OTA
|
|
d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT
|
|
β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Tyr-NH29]OVT,
d(CH2)5[O-Me-Tyr2-Thr4-Orn8-Tyr9-NH2]vasotocin,
Pmp[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin
|
|
[D-Cys(tBu)5]NPS
|
|
|
[3H]d[D-Arg8]VP
|
|
[3H][D-Arg8]vasopressin,
[3H]DAVP,
[3H]-d[D-Arg8]VP
|
[3H]dDAVP
|
|
[3H]1-deamino,D-AVP,
[3H]d[D-Arg8]AVP,
[3H]deamino arginine vasopressin,
[3H][deamino-Cys1,D-Arg8]vasopressin,
[3H]desmopressin
|
|
d[D-Pal2]AVP
|
|
d[D-3-Pal2]VP,
deamino1(D-3-(Pyridyl)Ala2-Arg8)-Vasopressin,
deamino1[D-3-(pyridyl)Ala2]AVP,
[desamino1-Cys,D-Pal2]AVP,
desamino1D-3-(pyridyl)Ala2-Arg8)AVP,
d[D-3-Pal2]AVP
|
|
d[D-Phe2]AVP
|
|
[deamino-Cys1,D-Phe2]AVP
|
|
degarelix
|
|
FE200486,
Firmagon
|
|
deltorphin II
|
|
(Ala(2))deltorphin II,
(Ala(2),glu(4))deltorphin,
alanyl(2)-glutamyl(4)-deltorphin,
Delt II,
Delt-II,
deltorphin-II
|
[3H]deltorphin II
|
|
[3H]-deltorphin II
|
|
demotate 2
|
|
N(4) (0-1),Asp0,Tyr3-octreotate
|
|
α-dendrotoxin
|
|
α-DTX
|
|
dendrotoxin-1
|
|
dendrotoxin,
dendrotoxin I,
venom basic protease inhibitor 1
|
|
Des-AA1,2,5,12,13-[D-Trp8]SRIF
|
|
|
|
Des-AA5-[D-Trp8]SRIF
|
|
|
|
Des-AA1,5-[Tyr2,D-Trp8,IAmp9]SRIF
|
|
CH-288
|
|
(des 1-8) A-chain INSL3 analogue
|
|
|
|
Des-Ala1,2,5-[D-Trp8,IAmp9]SRIF
|
|
|
|
[des-Arg10]icatibant
|
|
[des-Arg10]HOE140,
[D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]-des-Arg9]bradykinin
|
|
[des-Arg11]T-kinin
|
|
[Ile,Ser,des-Arg9]bradykinin
|
|
[des-Gly10,D-Ala6]GnRH N-ethylamide
|
|
|
[125I][des-Gly10,D-Ala6]GnRH N-ethylamide
|
|
|
|
desGlyNH2-d(CH2)5[Tyr(Me)2,Thr4,Orn8]OT
|
|
|
[3H]desGly-NH2[D-Ile2,Ile4]VP
|
|
[3H]-desGly-NH2[D-Ile2,Ile4]AVP
|
|
des-His1-[Glu9]glucagon-NH2
|
|
des-His(1)-[Glu9]-glucagon-NH2
|
|
des-His1-[Leu4-Glu9]glucagon-NH2
|
|
des-His(1)-[Leu4-Glu9]-glucagon-NH2
|
|
desmopressin
|
|
1-deamino,D-AVP,
dDAVP,
[deamino-Cys1,D-Arg8]vasopressin
|
|
[des-Phe9,des-Arg10]kallidin
|
|
[Lys,des-Phe8,Arg9]bradykinin
|
|
[des-Pro8,des-Phe9,des-Arg10]kallidin
|
|
[des-Pro7,Phe8,Arg9]Lys-bradykinin
|
|
DFGYVAE
|
|
|
|
DkTx
|
|
Double-knot toxin
|
|
d[Leu4]AVP
|
|
[deamino-Cys1,Leu4,Arg8]vasopressin
|
|
d[Leu4,Dap8]VP
|
|
[deamino-Cys1,Leu4,Dap8]vasopressin
|
|
d[Leu4]LVP
|
|
[deamino-Cys1,Leu4,Lys8]vasopressin,
d[Leu4]lysine vasopressin,
d[Leu4,Lys8]VP
|
|
D-Lys0-[des-Arg10]kallidin
|
|
D-[Lys,Lys,des-Arg9]bradykinin
|
|
[D-Lys1,des-Arg10]kallidin
|
|
D-[Lys,des-Arg9]bradykinin
|
|
[D-Lys6]GnRH-II
|
|
|
|
1DMe
|
|
[D-Tyr1,(NMe)Phe3]neuropeptide FF,
[D.Tyr1,(N.Me)Phe3]NPFF
|
[125I]1DMe
|
|
|
|
dNal-cyc(Cys-Tyr-dTrp-Orn-Val)-Nal-NH2
|
|
D-Nal-Cys-Tyr-D-Trp-Orn-Val-Cys-Nal-NH2
|
|
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2
|
|
|
|
dNPA
|
|
|
|
DOTA-BASS
|
|
DOTA-BASS analog 2
|
[111In]DOTA-BOC-ATE
|
|
[InIII-DOTA]-BOC-ATE,
[InIII-DOTA]-BOC-ATE,
[111In-DOTA]-BOC-ATE
|
[111In]DOTA-dLVT
|
|
[111indium]DOTA-dLVT,
[111In]-DOTA-dLVT,
[111In]-DOTA-Lys8-deamino-vasotocin
|
[111In,90Y]DOTA-LAN
|
|
DOTA-conjugated peptide,
YIII-DOTA-LAN
|
[111In]DOTA-NOC
|
|
[InIII-DOTA]-NOC,
[InIII-DOTA]-NOC,
[111In-DOTA]-NOC
|
[111In,90Y]DOTA-NOC
|
|
[90Y-DOTA]-1-Nal3-octreotide,
90Y-DOTA-NOC,
YIII-DOTA-NOC
|
[111In]DOTA-NOC-ATE
|
|
[InIII-DOTA]-NOC-ATE,
[InIII-DOTA]-NOC-ATE,
[111In-DOTA]-NOC-ATE
|
[111In,90Y]DOTA-OC
|
|
[3Y]DOTA-OC,
[3Y]DOTA-octreotide,
YIII-DOTA-OC
|
[111In,90Y]DOTA-TOC
|
|
YIII-DOTA-TOC,
YIII-DOTA-TOC,
YIII-DOTA-Tyr3-octreotide
|
|
DPDPE
|
|
2,5-Pen-enkephalin,
(4S,7S,13S)-13-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-7-benzyl-3,3,14,14-tetramethyl-6,9,12-trioxo-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxylic acid,
Bis-penicillamine-enkephalin,
Dpdpe(SH)2,
[D-Pen2,5]enkephalin,
[d-Pen2,d-Pen5]-Enkephalin,
D-Penicillamine (2,5)-enkephalin,
DPLPE
|
[3H]DPDPE
|
|
[3H]-DPDPE,
[3H]-[d-Pen2,d-Pen5]-Enkephalin
|
|
d[Pen1,Tyr(Me)2]AVP
|
|
1-Deaminopenicillamine-2-(O-methyl-tyr)-argipressin,
dPTyr(Me)AVP
|
|
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14)
|
|
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin(6-14)
|
|
[D-Phe6,(R)-APA11,Phe13,Nle14]bombesin-(6-14)
|
|
[D-Phe6,(R)-APA11,Phe13,Nle14]bombesin(6-14)
|
|
[D-Phe6,Cpa14,ψ13-14]bombesin-(6-14)
|
|
[D-Phe6,Cpa14,ψ13-14]bombesin6-14,
[D-Phe6,Leu13,Cpa14,ψ13-14]bombesin-(6-14)
|
|
D-Phe-CRF-(12-41)
|
|
D-Phe-corticotropin-releasing factor(12-41),
D-Phe-CRF(12-41),
D-Phe12,Nle21,38,αMeLeu37-CRF
|
|
DSLET
|
|
Dislet,
[D-Ser2, Leu5, Thr6]-enkephalin,
DSTLE,
tyrosyl-seryl-glycyl-phenylalanyl-leucyl-threonine
|
|
DSTBULET
|
|
AC1L2XS7
|
|
[D-Trp2]galanin-(1–29)
|
|
[D-Trp2]galanin(1–29)
|
|
[D-Trp8]γ-MSH
|
|
D-Trp8 γ-melanocyte stimulating hormone,
D-Trp8 γ-MSH,
D-Trp8-y-MSH
|
|
[D-Trp11]neurotensin
|
|
D-Trp11-neurotensin
|
|
[D-Trp32]NPY
|
|
[D-Trp32] neuropeptide Y,
[D-Trp32]-NPY
|
|
[D-Trp12]PTH-(7-34) (bovine)
|
|
[D-Trp12]-PTH 7-34 (bovine)
|
|
[D-Trp12,Tyr34]PTH-(7-34) (bovine)
|
|
[D-Trp12,Tyr34]-PTH 7-34 (bovine)
|
|
[125I]α-DTX
|
|
|
[125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin-(6-14)
|
|
[125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin(6-14),
[125I]-[Tyr6,βAla11,Phe13,Nle14] bombasin-6-14
|
|
[D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin-(6-14)
|
|
[D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin6-14
|
[125I][D-Tyr6]bombesin-(6-13)-methyl ester
|
|
|
|
[D-Tyr8]CYN 154806
|
|
cyanamid 154806,
CYN 154806,
D-Tyr8-CYN 154806
|
|
duramycin
|
|
|
|
d[Val4,DArg8]VP
|
|
|
|
[D-Val5]NPS
|
|
|
|
dVDAVP
|
|
1-deamino-4-val-8-arg-vasopressin,
[deamino-Cys1,Val4,D-Arg8]AVP,
d[Val4]AVP
|
|
DW13.3
|
|
DW13.3 toxin,
ω-filistatoxin-Kh1a,
ω-FLTX-Kh1a
|
|
[dY]1KP-10
|
|
|
|
dynorphin-(1-11)
|
|
dynorphin 1-11,
dynorphin A (1-11)
|
|
dynorphin-(1-17)-NH2
|
|
dynorphin 1-17-NH2
|
| |
| E |
Back to top |
|
E2078
|
|
1-N-Me-Tyr(1)-7-N-Me-arg-8-N-Et-leunh2-dynorphin (1-8),
N-methyltyrosyl1-N-methylarginyl7-N-ethylleucinamide8-dynorphin(1-8),
N-methyl-Tyr1,N-methyl-Arg7,D-leu8-dynorphin-A(1-8),
N-Me-tyr(1)-N-Me-arg(7)-N-Et-leunh2(8)-dynorphin (1-8)
|
|
E7
|
|
C3a receptor superagonist,
(Trp63-Trp64)-C3a-(63-77)
|
|
EC 5-21
|
|
|
|
E. coli heat-stable enterotoxin (STa)
|
|
|
|
EFWSLAAPQRF-NH2
|
|
EFW-NPSF
|
[125I]EGF (human)
|
|
[125I]-epidermal growth factor
|
|
EISAI-1
|
|
|
|
EISAI-2
|
|
|
|
eledoisin
|
|
ELD 950,
eledone peptide
|
|
ErgTx-1
|
|
|
[125I]ET-1
|
|
[125I]endothelin-1
|
[125I]ET-2
|
|
[125I]endothelin-2
|
[18F]ET-1
|
|
[18F]endothelin-1
|
|
etanercept
|
|
Enbrel
|
|
europium-labelled H3-B/INSL5 A chimera
|
|
Eu-R3/I5
|
|
europium-labelled H2 relaxin
|
|
|
|
europium-labelled INSL3
|
|
|
|
europium-labelled INSL5
|
|
|
|
exendin-3
|
|
|
|
exendin-4
|
|
exenatide
|
|
exendin-(9-39)
|
|
exendin (9-39)
|
[125I]exendin
|
|
[125I]-exendin
|
[125I]exendin-(9-39)
|
|
[125I]exendin (9-39)
|
[125I]EYF
|
|
[125I]-EYF
|
[3H]EYF
|
|
[3H]-EYF
|
| |
| F |
Back to top |
|
F180
|
|
[2-hydroxy-3-mercaptopropionic acid-1, Phe-2, Hgn-4. Dab(Abu)-8]OT,
F 180
|
|
[F/G]N/OFQ-(1-13)-NH2
|
|
[F/G]nociceptin(1-13)NH2,
[F/G]nociceptin/orphanin FQ(1-13)NH2,
[F/G]N/OFQ(1-13)NH2,
[F/G]orphanin FQ(1-13)NH2
|
|
FK 224
|
|
N-[N2-[N-[N-[N-[2,3-didehydro-N-methyl-N-[N-[3-(2-pentylphenyl)-propionyl]-L-threonyl]tyrosyl-L-leucynyl]-D-phenylalanyl]-L-allo-threonyl]-L-asparaginyl]-L-serine-ν-lactone
|
|
FLPLAR
|
|
|
|
FLTChaAR
|
|
|
F2L-[125I]Tyr
|
|
|
|
Flu-CCL3
|
|
Flu-LD78α,
Flu-MIP-1α,
fluorescent macrophage inflammatory protein-1α
|
|
4-fluorobenzoyl-FGLRW-NH2
|
|
|
|
fMet-Ile-Phe-Leu
|
|
fMet-Ile-Phe-Leu [S. aureus]
|
|
fMet-Ile-Val-Ile-Leu
|
|
fMet-Ile-Val-Ile-Leu [L. monocytogenes]
|
|
fMet-Ile-Val-Thr-Leu-Phe
|
|
fMet-Ile-Val-Thr-Leu-Phe [L. monocytogenes]
|
|
fMet-Leu-Phe
|
|
fMetLeuPhe,
fMet-Leu-Phe [E. coli ],
fMLP,
formyl-Met-Leu-Phe
|
[3H]fMet-Leu-Phe
|
|
[3H]fMet-Leu-Phe,
[3H]fMLP
|
|
fMet-Leu-Phe-Glu
|
|
fMet-Leu-Phe-Glu [E. coli]
|
|
fMet-Leu-Phe-Ile-Ile-Lys-FITC
|
|
|
|
fMet-Met-Trp-Leu-Leu
|
|
|
|
fMet-Met-Tyr-Ala-Leu-Phe
|
|
fMet-Met-Tyr-Ala-Leu-Phe [Mitochondria]
|
|
FMRFamide
|
|
Phe-Met-Arg-Phe-amide
|
|
FSH deglycosylated α/β
|
|
|
[125I]FSH (human)
|
|
[125I]-follicle-stimulating hormone,
[125I]-FSH
|
|
FSH α subunit-deglycosylated form
|
|
|
|
FSH β subunit-deglycosylated form
|
|
|
2-furoyl-LIGRL[N[3H]propionyl]-O-NH2
|
|
[3H]propionyl-2fLI
|
|
2-furoyl-LIGRLO-amide
|
|
|
| |
| G |
Back to top |
|
Ga-DOTA-NOC
|
|
|
|
Ga-DOTA-TOC
|
|
DOTA0-Phe1-Tyr3-octreotide,
DOTA-Tyr3-octreotide,
edotreotide,
Ga-DOTATOC,
SMT487
|
|
[Ga-DOTA,Tyr3,Thr8]octreotide
|
|
Ga-DOTA-octreotate,
Ga-DOTATATE,
Ga-DOTA-TATE
|
|
Ga-KE88
|
|
|
|
galanin-(1-11)
|
|
galanin (1-11)
|
|
galanin-(2-11)
|
|
galanin (2-11)
|
|
galanin-(2–29) (rat)
|
|
galanin (2–29)
|
|
ganirelix
|
|
D 24598,
orgalutran,
RS 26306
|
|
Ga-NODAGA-LM3
|
|
|
[125I]gastrin
|
|
[125I]-gastrin
|
[3H]gastrin
|
|
[3H]-gastrin
|
[125I]gastrin-(1–17) (human)
|
|
[125I]-gastrin(1–17) ,
[125I]gastrin (1–17) (human)
|
|
gastrin-releasing peptide
{Sp: Pig}
|
|
|
|
GaTx1
|
|
Toxin GaTx1
|
|
GaTx2
|
|
|
[125I]GDNF (rat)
|
|
[125I]-GDNF (rat)
|
|
gG-2p20
|
|
|
[125I]GHRH (human)
|
|
[125I]-GHRH,
[125I]GHRH(1-44)NH2,
[125I]-growth hormone releasing hormone,
[125I]-Tyr10-hGHRH(1-44)NH2
|
|
GHRH-(1-29)-NH2 (human)
|
|
GHRH (1-29)NH2 (human),
human growth hormone releasing hormone (1-29)NH2
|
|
GHRH-(1-29)-NH2 (rat)
|
|
GHRH(1-29)NH2 (rat),
rat growth hormone releasing hormone (1-29)NH2
|
|
GHRH-(1-29)-OH (human)
|
|
GHRH(1-29)OH (human),
human growth hormone releasing hormone (1-29)OH
|
|
GHRP-2
|
|
growth hormone-releasing peptide-2,
KP 102,
pralmorelin
|
|
GHRP-6
|
|
GH-Releasing hexapeptide 6,
growth hormone releasing hexapeptide,
growth hormone releasing peptide-6,
Skf 110679
|
|
GIP-(10-30)
|
|
gastric inhibitory polypeptide10-30,
GIP10-30
|
|
GIP-(7-30)
|
|
gastric inhibitory polypeptide7-30,
GIP7-30
|
[125I]GIP
|
|
[125I]gastric inhibitory polypeptide,
[125I]-GIP
|
|
GIP-(6-30)-amide
|
|
gastric inhibitory polypeptide6-30 amide,
GIP6-30 amide
|
|
[Gln8]GnRH
|
|
chicken GnRH
|
[125I]GLP-1-(7-37)
|
|
[125I]-GLP-1(7-37),
[125I]GLP-1(7-37),
[125I]-glucagon-like peptide-1(7-37)
|
[125I]GLP-1-(7-36)-amide
|
|
[125I]GLP-1,
[125I]-GLP-1-(7-36) amide,
[125I]GLP-1(7-36)amide,
[125I]glucagon-like peptide 1 (7-36)
|
[125I][Glp65Nle75,Tyr77]apelin-13
|
|
[125I]-[Glp65Nle75,Tyr77]apelin-13,
[125I][Glu65,Nle75,Tyr77]apelin-13,
[125I](Pyr1)[Nle75,Tyr77]-apelin-13
|
|
GLP-2-(1-29) (rat)
|
|
GLP-2 (1-29) (rat),
rat glucagon-like peptide 2 (1-29)
|
|
glucagon-(1-21)
|
|
glucagon 1-21
|
|
glucagon-(1-6)
|
|
glucagon 1-6
|
[125I]glucagon (human, mouse, rat)
|
|
[125I]-glucagon
|
|
GM-109
|
|
GM109
|
[125I]GnRH I (human, mouse, rat)
|
|
[125I]-GnRH I,
[125I]-gonadotropin-releasing hormone I
|
[125I]GnRH II (human)
|
|
[125I]-GnRH II,
[125I]-gonadotropin-releasing hormone II
|
|
GnRH III
|
|
gonadoliberin-3,
gonadoliberin III,
Gonadotropin-releasing hormone III,
lamprey GnRH III,
Luliberin III
|
|
goserelin
|
|
decapeptide I,
ICI 118630,
zoladex
|
|
GR138676
|
|
GR 138676
|
|
GR231118
|
|
1229U91,
GR 231118,
GW1229,
GW 1229,
homodimeric Ile-Glu-Pro-Dpr-Tyr-Arg-Leu-Arg-Tyr-CONH2
|
|
GR64349
|
|
GR 64349,
L-lysyl-L-α-aspartyl-L-seryl-L-phenylalanyl-N-{1-[(1S)-1-{[(1S)-1-carbamoyl-3-(methylsulfanyl)propyl]carbamoyl}-3-methylbutyl]-2-oxopyrrolidin-3-yl}-L-valinamide,
Lys-Asp-Ser-Phe-Val-Gly-(R-γ-lactam)
|
|
GR94800
|
|
GR 94800
|
[125I]GR231118
|
|
[125I]1229U91,
[125I]GW1229
|
[3H]GR100679
|
|
[3H]-GR100679
|
|
ω-grammotoxin SIA
|
|
GrTx,
omega-Grammotoxin SIA
|
[125I]GRP (human)
|
|
[125I]-gastrin-releasing peptide,
[125I]-GRP
|
|
GsMTx-4
|
|
M-theraphotoxin-Gr1a
|
|
GYPGKF-NH2
|
|
|
|
GYPGQV-NH2
|
|
|
| |
| H |
Back to top |
[3H]haTRAP
|
|
Ala-p-fluoroPhe-Ala-Arg-cyclohexylAla-homoArg-[3H]Tyr-amide,
[3H]-haTRAP
|
[125I]H3-B/INSL5 A chimera
|
|
[125I]-H3-B/INSL5 A chimera
|
|
H-c[Cys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH
|
|
|
|
H-c[Cys-Phe-LAgl(NβMe,benzoyl)-Trp-Lys-Thr-Phe-Cys]-OH
|
|
|
|
H-c[DCys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH
|
|
|
|
α-helical CRF
|
|
α-helical corticotropin,
α-helical CRF (9-41),
alpha-helical CRF (9-41)
|
|
helodermin
|
|
Exendin 2
|
|
heteropodatoxin-2
|
|
HpTX2,
HpTx2,
κ-sparatoxin-Hv1b,
κ-SPRTX-Hv1b,
Toxin KJ6
|
|
hexarelin
|
|
Examorelin
|
|
Hip-His Leu
|
|
Hippuryl-His-Leu
|
|
[His5,Arg19]PTH-(1-34) (human)
|
|
[His5,Arg19]-PTH 1-34 (human)
|
|
[His5,D-Tyr6]GnRH
|
|
|
[125I][His9]ghrelin (human)
|
|
[125I-His9]ghrelin,
[125I] His9-ghrelin (human)
|
|
[His5]PTH-(1-34) (human)
|
|
[His5]-PTH 1-34 (human)
|
|
histrelin
|
|
ORF 17070,
RWJ 17070,
vantas
|
|
[His4, Tyr5, Trp6, His7]TIP39 (human)
|
|
[His4, Tyr5, Trp6, His7]-hTIP39,
[His4, Tyr5, Trp6, His7]-TIP39 (human),
HYWH-TIP39
|
|
HIV-Tat
|
|
Tat1-86
|
|
HmTx1
|
|
Heteroscodratoxin-1,
κ-theraphotoxin-Hm1a,
κ-TRTX-Hm1a
|
|
HmTx2
|
|
heteroscodratoxin-2,
κ-theraphotoxin-Hm2a,
κ-TRTX-Hm2a
|
|
hongotoxin-1
|
|
HgTX1,
potassium channel toxin α-KTx 2.5
|
|
Host-derived peptides, amyloidogenic
|
|
|
|
Host-derived peptides, non-amyloidogenic
|
|
|
|
Hp(2-20)
|
|
|
[125I]Hpp-desArg10HOE140
|
|
[125I]-Hpp-desArg9HOE140
|
[125I]H2 relaxin
|
|
[125I]-H2 relaxin
|
[125I]H3 relaxin
|
|
[125I]human gene 3 relaxin
|
[33P]H2 relaxin
|
|
[33P]Human gene 2 relaxin
|
|
H3 relaxin/INSL5 chimera
|
|
H3-B/INSL5 A chimera,
H3 relaxin B-chain/INSL5 A-chain chimera
|
|
HS014
|
|
HS 014
|
|
HS024
|
|
cyclic[AcCys3,Nle4,Arg5,D-Nal7,Cys-NH2(11)]alpha-MSH-(3-11),
HS 024
|
|
5-HT-moduline
|
|
|
|
[Hyp3,Tyr(Me)8]BK
|
|
[Hyp3,Tyr(Me)8]bradykinin
|
| |
| I |
Back to top |
|
iberiotoxin
|
|
|
|
i-Boc-Met-Leu-Phe
|
|
|
|
icatibant
|
|
HOE140,
HOE 140,
D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]BK
|
|
[Ile31,Gln34]PP (human)
|
|
human [Ile31,Gln34] pancreatic peptide,
[Ile31,Gln34]-PP (human)
|
|
[Ile5,Glu19]PTHrP-(1-34) (human)
|
|
|
|
[Ile5,Glu19,Val21]PTHrP-(1-34) (human)
|
|
[Ile5,Glu19,Val21]-PTHrP 1-34 (human)
|
|
[Ile5]PTHrP-(1-36)
|
|
[Ile5]-PTHrP 1-36
|
|
[Ile5]PTHrP-(1-34) (human)
|
|
[Ile5]-PTHrP 1-34 (human)
|
|
[Ile5]PTHrP-(1-36) (human)
|
|
[Ile5]-PTHrP 1-36 (human)
|
|
[Ile5,Trp23]PTHrP-(5-36)
|
|
[Ile5,Trp23]-PTHrP 5-36
|
|
[Ile5,Trp23]PTHrP-(1-36) (human)
|
|
[Ile5,Trp23]-PTHrP 1-36 (human)
|
|
[Ile5,Trp23]PTHrP-(2-36) (human)
|
|
[Ile5,Trp23]-PTHrP 2-36 (human)
|
|
[Ile5,Trp23]PTHrP-(3-36) (human)
|
|
[Ile5,Trp23]-PTHrP 3-36 (human)
|
|
[Ile5,Trp23]PTHrP-(4-36) (human)
|
|
[Ile5,Trp23]-PTHrP 4-36 (human)
|
|
[Ile5,Trp23]PTHrP-(5-36) (human)
|
|
[Ile5,Trp23]-PTHrP 5-36 (human)
|
|
[Ile5,Trp23,Tyr36]PTHrP-(1-36)-NH2 (human)
|
|
[Ile5,Trp23,Tyr36]-PTHrP 1-36-NH2 (human)
|
|
[Ile5,Val21]PTHrP-(1-34) (human)
|
|
[Ile5,Val21]-PTHrP 1-34 (human)
|
|
In-NODAGATOC
|
|
In-NODAGA-Tyr3-octreotide
|
|
INSL3 B-chain analogue
|
|
|
[125I]INSL3 (human)
|
|
|
[125I]INSL5 (human)
|
|
[125I]insulin-like peptide 5
|
[125I](3-iodo-Tyr13)-MCH
|
|
|
|
IRL 1620
|
|
IRL1620,
IRL2620,
Suc[Glu9,Ala11,15]ET-110–21
|
|
IRL 2500
|
|
N-(3,5-dimethylbenzoyl)-N-methyl-(D)-(4-phenylphenyl)-Ala-Trp
|
[125I]IRL1620
|
|
[125I]-IRL1620,
[125I]IRL 1620
|
|
isopropylureido-FLFLF
|
|
|
| |
| J |
Back to top |
|
jingzhaotoxin-III
|
|
β-theraphotoxin-Cj1a,
β-TRTX-Cj1a,
Jingzhaotoxin-3,
JZTX-III,
Peptide F5-20.38
|
|
jingzhaotoxin-XI
|
|
Jingzhaotoxin-11,
JZTX-11,
JZTX-XI,
κ-theraphotoxin-Cj1a,
κ-TRTX-Cj1a
|
|
JMV1116
|
|
JMV 1116
|
|
JMV1431
|
|
|
|
JMV180
|
|
Boc-Tyr(SO3H)Ahx-Gly-Trp-Ahx-Asp2phenylethyl ester,
JMV-180
|
|
JMV2004
|
|
JMV 2004
|
|
JMV310
|
|
JMV 310
|
|
JMV431
|
|
JMV 431
|
|
JMV449
|
|
JMV 449
|
|
JMV457
|
|
tert-butoxy-carbonyl-Arg-Arg-Pro-D-Tyr-Ile-Leu-OH,
JMV 457
|
|
JMV458
|
|
JMV 458
|
|
JMV594
|
|
[D-Phe6,Statine13]Bombesin(6-14),
JMV 594
|
|
JMV641
|
|
JMV-641
|
|
JPE1375
|
|
JPE 1375
|
|
JV-1-10
|
|
[PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Arg9,Abu15,Nle27, D-Arg29]hGH-RH(1-29)NH2
|
|
JV-1-36
|
|
JV 1-36,
[PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Arg9,Abu15,Nle27,D-Arg28,Har29]hGH-RH(1-29)NH2
|
|
JV-1-37
|
|
|
|
JV-1-38
|
|
JV 1-38,
[PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Har9,Tyr(Me)10,Abu15,Nle27,D-Arg28,Har29]hGH-RH(1-29)NH2
|
|
JV-1-39
|
|
|
|
JV-1-40
|
|
|
|
JV-1-41
|
|
|
|
JV-1-42
|
|
JV 1-42
|
|
JV-1-43
|
|
|
|
JV-1-62
|
|
|
|
JV-1-63
|
|
JV 1-63
|
| |
| K |
Back to top |
|
K31440
|
|
Ac-(D-Tyr11,His12,Nle17)sauvagine(11-40)
|
|
K41498
|
|
[D-Phe11,His12,Nle17]sauvagine(11-40)
|
|
kaliotoxin
|
|
BmKTX,
KTX,
potassium channel toxin α-KTx 3.6
|
|
kassinin
|
|
|
[125I]KC-Tyr
|
|
|
|
KE 108
|
|
|
|
KH28
|
|
KH 28
|
|
kisspeptin-15
|
|
KP-15
|
|
kisspeptin-28
|
|
KP-28
|
|
kisspeptin-9
|
|
KP-9
|
[125I]kisspeptin-10 (human)
|
|
[125I]-KP10,
[125I]KP-10
|
[125I]kisspeptin-13 (human)
|
|
[125I]-kisspeptin13,
[125I]KP13,
[125I]-KP13
|
[125I]kisspeptin-14 (human)
|
|
[125I]KP14
|
[125I]kisspeptin-54 (human)
|
|
[125I]KP-54,
[125I]metastin
|
|
α-KTx 13.2
|
|
OsK2
|
|
kurtoxin
|
|
Ktx
|
| |
| L |
Back to top |
|
L-156,602
|
|
Antibiotic L 156602,
L 156602,
PD 124966
|
|
L-362,823
|
|
L 362823
|
|
L-362,855
|
|
L 362855
|
|
L-363,301
|
|
L 363301,
L 363568,
MK 301,
MSD-L 363301
|
|
L-363,377
|
|
|
|
L-363,409
|
|
L 363409,
MK 363-409
|
|
L-365,209
|
|
Cyclo(L-isoleucyl-D-2,3,4,5-tetrahydro-3-pyridazinecarbonyl-L-2,3,4,5-tetrahydro-3-pyridazinecarbonyl-N-methyl-D-phenylalanyl-L-prolyl-D-phenylalanyl),
L 365209
|
|
L-366,682
|
|
Cyclo(D-histidyl-L-prolyl-D-tryptophyl-L-isoleucyl-D-2-piperidinecarbonyl-L-2-piperidinecarbonyl),
cyclo(Pro-Trp-Ile-Pip-Pip-His),
L 366682
|
|
L-366,875
|
|
L 366875
|
|
L-366,948
|
|
Cyclo(3-(2-naphthalenyl)-D-alanyl-L-isoleucyl-D-2-piperidinecarbonyl-L-2-piperidinecarbonyl-D-histidyl-L-prolyl),
L 366948
|
|
labradimil
|
|
cereport,
H-6578,
[Hyp3,Thi5,4-Me-Tyr8ψ(CH2-NH)Arg9]bradykinin,
Labrodimil,
lobradimil,
RMP 7,
RMP-7
|
|
lanreotide
|
|
Angiopeptin,
Autogel,
BIM 23014,
DC 13-116,
Ipstyl,
Somatulin
|
|
[L-Bpa5,Ile13]motilin (human)
|
|
|
|
Lei-Dab7
|
|
|
|
leiurotoxin I
|
|
Leiurotoxin-1,
LeTx I,
MFCD00671413,
potassium channel toxin α-KTx 5.1,
scyllatoxin,
ScyTx
|
|
[Leu14, ψ 13-14)]bombesin
|
|
|
|
[Leu8,des-Arg9]bradykinin
|
|
|
|
[Leu9,des-Arg10]kallidin
|
|
Lys-[Leu8][des-Arg9]BK,
[Lys,Leu8,des-Arg9]bradykinin,
Lys-[Leu8][des-Arg9]bradykinin
|
|
[Leu13]motilin (human)
|
|
|
[3H]Leu-N/OFQ
|
|
[3H]-Leu-nociceptin.orphanin FQ,
[3H]-Leu-N/OFQ
|
|
leuprolide
|
|
leuprorelin,
lupron
|
|
[Leu31,Pro34]NPY
|
|
[Leu31,Pro34] neuropeptide Y,
[Leu31,Pro34]-NPY
|
[125I][Leu31,Pro34]NPY
|
|
[125I]-[Leu31,Pro34]neuropeptide Y,
[125I]-[Leu31,Pro34]NPY
|
|
[Leu31,Pro34]NPY (pig)
|
|
porcine [Leu31,Pro24] neuropeptide Y,
porcine [Leu31,Pro34] neuropeptide Y
|
|
[Leu31,Pro34]PYY (human)
|
|
human [Leu31,Pro34] peptide tyrosine tyrosine,
human [Leu31,Pro34] peptide YY
|
|
[Leu31,Pro34]PYY (pig)
|
|
[Leu31,Pro34] peptide tyrosine tyrosine,
[Leu31,Pro34] peptide YY
|
|
LGR7-truncate
|
|
|
[125I]LH
|
|
[125I]-LH,
[125I]-luteinising hormone,
[125I]-luteinizing hormone
|
|
linaclotide
|
|
|
|
liraglutide
|
|
Liraglutida,
Liraglutidum,
N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide,
NN2211,
NN-2211 ,
UNII-839I73S42A,
victoza
|
|
litorin
|
|
Litorine
|
[125I]LTT-SRIF-28
|
|
3-[125I](Leu8, D-Trp22, Tyr25)somatostatin-28,
3-[125I]LTT-SRIF-28,
[125I](Leu8, D-Trp22, Tyr25)-somatostatin-28
|
|
[L-Tyr8]CYN 154806
|
|
cyanamid 154806
|
|
LVP
{Sp: Pig}
|
|
lysine vasopressin,
lysipressin,
lysopressin,
[Lys8]AVP,
[Lys8]-vasopressin,
syntopressin
|
|
[Lys15,Arg16,Leu27]VIP-(1–7)/GRF-(8–27)-NH2
|
|
[K15, Arg16, Leu27]VIP(1-7)/GRF(8-27)
|
[3H]Lys-[des-Arg9]BK
|
|
[3H]-Lys-[des-Arg9]BK,
[3H]-Lys-[des-Arg9]-bradykinin
|
|
Lys-kallidin
|
|
[Lys,Lys]bradykinin
|
[3H]Lys-[Leu8][des-Arg9]BK
|
|
[3H]-Lys-[Leu8][des-Arg9]BK,
[3H]-Lys-[Leu8][des-Arg9]-bradykinin
|
|
[Lys5,Me-Leu9,Nle10]NKA-(4-10)
|
|
[Lys5,Me-Leu9,Mle10]neurokinin A(4-10)
|
| |
| M |
Back to top |
|
M15
|
|
galanin(1–13)substance P(5–11)amide,
galantide
|
|
M32
|
|
galanin(1–13)neuropeptide Y-amide(25–36)amide
|
|
M35
|
|
galanin(1–13)bradykinin(2–9)amide
|
|
M372049
|
|
|
|
M40
|
|
galanin(1–13)Pro-Pro-Ala-Leu-Ala-Leu-Ala-Leu-Ala-amide
|
|
M65
|
|
des-(Gln25-Gln41)-maxadilan,
maxadilan Δ25-41
|
|
M871
|
|
galanin(2–13)Glu-His-(Pro)3(Ala-Leu)2Ala-amide
|
maltotriose-[125I][Tyr3,Thr8]octreotide
|
|
maltotriose-[125I]-Tyr3-octreotate,
[125I]-Mtr-TOCA
|
|
margatoxin
|
|
MgTx,
potassium channel toxin α-KTx 2.2
|
|
mast cell degranulating peptide
|
|
MCDP,
MCD peptide,
Peptide 401
|
|
maurotoxin
|
|
MTX,
potassium channel toxin α-KTx 6.2
|
|
maxadilan
|
|
|
|
Max.d.4
|
|
des-(Leu24-Leu42)-maxadilan,
maxadilan Δ24-42
|
|
MBP10
|
|
|
|
MCH6-17
|
|
melanin-concentrating hormone (6-17)
|
[125I]MCH (human, mouse, rat)
|
|
[125I]-melanin-concentrating hormone
|
[3H]MCH (human, mouse, rat)
|
|
[3H]-MCH,
[3H]-melanin-concentraing hormone
|
|
MCH (salmon)
|
|
salmon melanin-concentrating hormone
|
|
MC148R
|
|
MC 148,
MC 148 CC chemokine
|
|
MEN 10376
|
|
MEN-10,376,
neurokinin A(4-10), Tyr(5)-Trp(6,8,9)-Lys(10)- ,
[Tyr5,D-Trp6,8,9,Lys10]-alpha-NEUROKININ A, Fragment 4-10
|
|
MEN10627
|
|
cyc(2β–5β)(Met-Asp-Trp-Phe-Dap-Leu)
|
[125I][MePhe7]NKB
|
|
[125I]-[MePhe7]neurokinin A,
[125I]-[MePhe7]NKB
|
|
Met-Ckβ7
|
|
Ckβ7,
Met-chemokine β 7
|
|
[Met5]dynorphin-(1-17)
|
|
|
|
Met-Lys-bradykinin
|
|
Met-kallidin
|
|
Met-Met-Trp-Leu-Leu
|
|
|
|
Microbe-derived formyl and non-formyl peptides
|
|
|
|
mini-TyrRS
|
|
NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase
|
[125I]mini-TyrRS
|
|
125I-NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase
|
|
MIT1
|
|
mamba intestinal toxin-1
|
|
Mitochondria-derived formyl peptides
|
|
|
|
MK-678
|
|
seglitide
|
[125I]MK-678
|
|
|
|
motilin
{Sp: Dog}
|
|
|
|
motilin
{Sp: Rabbit}
|
|
|
|
motilin-(1-11) (human)
|
|
motilin1-11 (human)
|
|
motilin-(1-12) (human)
|
|
motilin1-12 (human)
|
|
motilin-(1-13) (human)
|
|
motilin1-13 (human)
|
|
motilin-(1-19) (human)
|
|
motilin1-19 (human)
|
|
motilin-(2-22) (human)
|
|
motilin2-22 (human)
|
[125I]motilin (human)
|
|
[125I]-Motilin
|
|
[Mpa1,D-Tyr(Et)2,D-Tic7,Aib9]OT
|
|
[deamino β-mercaptopropionic acid,-D-Tyr2,D-Tic7,Aib9]OT,
[Mpa1,O-ethyl-D-Tyr2,D-Tic7,Aib9]OT
|
|
[Mpa1,D-Tyr(Et)2,D-Tic7,D-Tic9]OT
|
|
[deamino β-mercaptopropionic acid,D-Tyr(Et)2,D-Tic7,D-Tic9]OT,
[Mpa1,O-ethyl-D-Tyr2,D-Tic7,D-Tic9]OT
|
|
[Mpa1,D-Tyr(Et)2,D-Tic7]OT
|
|
[deamino β-mercaptopropionic acid-D-Tyr(Et)2,D-Tic7]OT
|
|
MS05
|
|
|
|
MT1
|
|
muscarinic toxin 1
|
|
MT2
|
|
MTx2,
muscarinic toxin 2
|
|
MT3
|
|
muscarinic toxin 3
|
|
MT7
|
|
m1-toxin 1,
recommbinant mamba venom toxin,
rMT7
|
|
MT-II
|
|
melanotan II,
MTII
|
|
MZ-4-169
|
|
[Nac0,D-Arg2,Phe(4-Cl)6,Abu15,Nle27]hGHRH-(1-29) NH2
|
|
MZ-4-181
|
|
[Nac0-His1,D-Arg2,Phe(4-Cl)6,Abu15,Nle27]-hGH RH-(1-29)NH2
|
|
MZ-4-243
|
|
[Nac0,D-Arg2,Phe(4-CI)6,Abu15,Nle27]hGHRH-(1-28)Agm
|
|
MZ-4-71
|
|
MZ 4-71
|
|
MZ-5-156
|
|
MZ 5-156,
[PhAc-Tyr1,D-Arg2,Phe(4-Cl)6(para-chlorophenylalanine),Abu15 (7α-aminobutyric acid),Nle27]hGH-RH(1-28) agmatine (1-amino-4-guanidinobutane)
|
|
MZ-5-192
|
|
|
|
MZ-5-78
|
|
|
|
MZ-6-55
|
|
MZ 6-55,
[PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Abu15,Nle27,D-Arg28,Har29]hGH-RH(1-29)NH2
|
| |
| N |
Back to top |
|
N-α-Ac-PYY-(22-36) (rat)
|
|
N-α-Ac-PYY22-36 (rat)
|
|
N-α-Ac-PYY-(25-36) (rat)
|
|
N-α-Ac-PYY25-36 (rat)
|
|
nafarelin
|
|
|
|
NC 8-12
|
|
|
|
NC 4-28B
|
|
|
|
NDP-MSH
|
|
α-NDP-MSH,
[Nle4,dPhe7]α-MSH
|
[125I]NDP-MSH
|
|
[125I]-NDP-MSH,
[125I][Nle4,dPhe7]α-MSH
|
|
nepadutant
|
|
MEN11420,
MEN 11420
|
|
neuromedin U-8
{Sp: Dog}
|
NMU-8
|
canine neuromedin U-8
|
|
neuromedin U-25
{Sp: Pig}
|
NMU-25
|
porcine neuromedin U-25
|
|
neuromedin U-8
{Sp: Pig}
|
NMU-8
|
porcine neuromedin U-8
|
[125I]neuromedin U-25 (human)
|
[125I]NMU-25 (human)
|
[125I]neuromedin U,
[125I]neuromedin U-25,
[125I] neuromedin U (human),
[125I]NMU-25
|
[125I]neuromedin U-8 (pig)
|
[125I]NMU-8 (pig)
|
porcine [125I]neuromedin U-8
|
[125I]neuromedin U-23 (rat)
|
[125I]NMU-23 (rat)
|
rat [125I]neuromedin U-23
|
|
neuropeptide-α
|
|
|
|
neuropeptide head activator
|
|
HA
|
[125I]neurotensin (human, mouse, rat)
|
|
[125I]NT
|
[3H]neurotensin (human, mouse, rat)
|
|
[3H]-Neurotensin
|
[125I]NGF (human)
|
|
[125I]-nerve growth factor,
[125I]NGF
|
[125I]NKA (human, mouse, rat)
|
|
[125I]-neurokinin A,
[125I]-NKA
|
[125I][Nle75,Tyr77]apelin-36 (human)
|
|
|
|
[Nle8,18,Tyr34]PTH-(1-34)-NH2 (bovine)
|
|
|
|
[Nle8,18,Tyr34]PTH-(3-34)-NH2 (bovine)
|
|
|
[125I][Nle8,21,Tyr34]PTH-(1-34)-NH2 (rat)
|
|
|
|
[nLeu13,Glu14]motilin (human)
|
|
|
|
N-methyl-Phe-Lys-Pro-D-Cha-Cha-D-Arg-CO2H
|
|
|
|
N-methyl-Phe-Lys-Pro-D-Cha-Trp-D-Arg-CO2H
|
|
|
|
NOC-ATE
|
|
|
|
NODAGA-[Tyr3]-octreotide
|
|
NODAGATOC,
NODAGA-Tyr3-octreotide
|
[67Ga]NODAGA-[Tyr3]octreotide
|
|
[67Ga]-NODAGA-Tyr3-octreotide,
Ga-NODAGATOC
|
[3H]N/OFQ
|
|
[3H]nociceptin,
[3H]nociceptin/orphanin FQ,
[3H]orphanin FQ
|
|
N/OFQ-(1-13)-NH2
|
|
nociceptin(1-13)NH2,
nociceptin/orphanin FQ(1-13)NH2,
orphanin FQ(1-13)NH2
|
|
N/OFQ-NH2
|
|
nociceptin-NH2,
nociceptin/orphanin FQ--NH2,
orphanin FQ-NH2
|
|
noxiustoxin
|
|
NTx,
potassium channel toxin α-KTx 2.1,
Toxin II.11
|
|
NPC 17731
|
|
NPC17731,
D-Arg[Hyp3,trans-4-propoxy-D-proline(transpropyl)7,Oic8]bradykinin
|
|
NPC 18565
|
|
des-Arg9 fragment of NPC 17731,
[D-Arg(Hyp3,D-Hyp7(transpropyl),Oic8)des-Arg9]bradykinin
|
|
NPC-349
|
|
B 4162,
B 4307,
B 4881,
B 5630,
NPC 349,
PKB 4202,
[D-Arg0,Hyp2,3,Thi5,8,D-Phe7]bradykinin
|
|
NPC-567
|
|
BIM 31006,
NPC 567,
[D-Arg0,Hyp3,D-Phe7]bradykinin
|
[3H]NPC17731
|
|
[3H]-NPC17731
|
[125I]NPFF
|
|
[125I]-neuropeptide FF,
[125I]-NPFF
|
|
[Nphe1]N/OFQ-(1-13)-NH2
|
|
[Nphe1]nociceptin(1-13)NH2,
[Nphe1]nociceptin/orphanin FQ(1-13)NH2,
[Nphe1]orphanin FQ(1-13)NH2
|
|
3-N3-Phpa-LVA
|
|
|
[125I]3-N3-Phpa-LVA
|
|
|
[3H]NPVF
|
|
[3H]neuropeptide VF,
[3H]-NPVF
|
[125I]NPW-23 (human)
|
|
[125I]neuropeptide W,
[125I]neuropeptide W-23,
[125I]NPW
|
|
NPY-(13-36)
|
|
neuropeptide Y (13-36)
|
|
NPY-(2-36)
|
|
neuropeptide Y (2-36),
NPY2-26 (human),
NPY2-36 (mouse),
NPY2-36 (rat)
|
[125I]NPY
|
|
[125I]neuropeptide Y
|
[3H]NPY
|
|
[3H]neuropeptide Y
|
|
NPY
{Sp: Pig}
|
|
porcine neuropeptide Y
|
|
NPY-(13-36) (human)
|
|
human neuropeptide Y (13-36)
|
|
NPY-(18-36) (human, pig)
|
|
human neuropeptide Y (18-36),
porcine neuropeptide Y (18-36)
|
|
NPY-(13-36) (pig)
|
|
porcine neuropeptide Y (13-36)
|
|
NPY-(16-36) (pig)
|
|
porcine neuropeptide Y (16-36)
|
|
NPY-(20-36) (pig)
|
|
porcine neuropeptide Y (20-36)
|
|
NPY-(22-36) (pig)
|
|
porcine neuropeptide Y (22-36)
|
|
NPY-(2-36) (pig)
|
|
porcine neuropeptide Y (2-36)
|
|
NPY-(26-36) (pig)
|
|
porcine neuropeptide Y (26-36)
|
|
NPY-(3-36) (pig)
|
|
porcine neuropeptide Y (3-36)
|
|
N-stearyl-[Nle17] neurotensin-(6-11)/VIP-(7-28)
|
|
N-stearyl-[Nle17] neurotensin(6-11)/VIP(7-28),
(SN)VIPhybrid
|
|
N-stearyl-[Nle17]VIP
|
|
N-stearyl-[Nle17]vasoactive intestinal peptide
|
| |
| O |
Back to top |
|
octreotide
|
|
DRG-0115,
Longastatin,
Octreotida,
Octreotidum,
Sandostatin,
SMS 201,995
|
|
OH-LVA
|
|
|
[125I]OH-LVA
|
|
|
|
OHM-11526
|
|
[Phe3,Leu13]motilin (porcine)
|
[125I]orexin A (human, mouse, rat)
|
|
[125I]-orexin A
|
|
OSK1-K16-D20
|
|
[K16,D20]-OSK1
|
[3H]OT (human, mouse, rat)
|
|
[3H]oxytocin
|
| |
| P |
Back to top |
|
P05
|
|
AmP05,
leiurotoxin I-like toxin P05,
Potassium channel toxin α-KTx 5.2
|
|
PACAP-(6-38)
|
|
pituitary adenylate cyclase activating polypeptide (6-38)
|
[125I]PACAP
|
|
[125I]-PACAP
|
[125I]PACAP-27
|
|
[125I]-PACAP-27,
[125I]pituitary adenylate cyclase activating polypeptide-27
|
|
[p-aminoPhe6]ang II
|
|
[p-aminoPhe6] angiotensin II
|
|
PAMP-20
|
|
Human PAMP(1-20),
Proadrenomedullin N-terminal 20 peptide (human)
|
|
PAMP-12 (human)
|
|
Human PAMP(9-20),
proadrenomedullin N-terminal 20 Peptide (Human, 9-20)
|
|
pancreatic polypeptide
{Sp: Bovine}
|
PP
|
bovine pancreatic polypeptide
|
|
pancreatic polypeptide
{Sp: European common frog}
|
PP
|
frog pancreatic polypeptide
|
|
pandinotoxin-K α
|
|
Pi2,
Pi-2,
Potassium channel-blocking toxin 2,
potassium channel toxin α-KTx 7.1,
Toxin PiTX-K-α
|
|
PBC-264
|
|
pBC 264,
propionyl-BC264
|
[3H]PBC-264
|
|
[3H]propionyl-BC-264,
[3H]-Propionyl-BC264,
[3H]-Propionyl-BC-264
|
|
PBP10
|
|
|
[125I]PD151242
|
|
[125I](N-[{hexahydro-1-azepinyl}carbonyl])Leu(1-Me)-DTrp-DTyr,
[125I]-PD151242
|
|
pentagastrin
|
|
Peptavlon
|
|
[Pen5]-U (4-11) (human)
|
|
human [Pen5]-urotensin (4-11)
|
|
peptide 234
|
|
|
|
peptide III-BTD
|
|
|
|
[(pF)Phe4]N/OFQ-(1-13)-NH2
|
|
[(pF)Phe4]nociceptin(1-13)NH2,
[(pF)Phe4]nociceptin/orphanin FQ(1-13)NH2,
[(pF)Phe4]orphanin FQ(1-13)NH2
|
|
PG-901
|
|
PG901
|
|
PG 97-269
|
|
[Acetyl-His1,D-Phe2,Lys15,Arg16,Leu17]VIP(3-7)/GRF(8-27)
|
|
PG 99-465
|
|
Myr-His1[Lys12,Lys27,28,Gly29,30,Thr31]VIP,
PG99-465
|
|
p-guanidinobenzoyl-MCH-(7-17)
|
|
|
|
[Phaa1,D-Tyr(Et)2,Lys6,des-Gly9]AVP
|
|
|
|
[Phaa1,D-Tyr(Et)2,Val4,Lys6,Tyr-NH28,des-Gly9]AVP
|
|
TyrPhaa
|
|
[Phaa1,D-Tyr(Me)2,Arg6,Tyr-NH29]AVP
|
|
|
|
[Phaa1,D-Tyr2,Val4,Arg6,Arg-NH29]AVP
|
|
|
|
[Phe13]bombesin
|
|
|
|
[Phe8,ψ(CH2-NH)Arg9]BK
|
|
[Phe8,ψ(CH2-NH)Arg9]bradykinin
|
|
[Phe3,Leu13]motilin (human)
|
|
|
|
[Phe(Me)7]neurokinin B
|
|
[MePhe7]NKB
|
|
[Phe3]OT
|
|
oxypressin,
[Phe3]oxytocin
|
|
[Phe2]OVT
|
|
[Phe2,Orn8]vasotocin
|
|
[Phe23]PTH-(1-34) (human)
|
|
|
|
[Phe13,Tyr19]MCH
|
|
[Phe13,Tyr19]-melanin-concentrating hormone
|
[125I][Phe13,Tyr19]MCH
|
|
[Phe13,[125I]Tyr19]MCH,
[Phe13,[125I]Tyr19]melanin-concentrating hormone
|
|
PHI
{Sp: Pig}
|
|
peptide histidine-isoleucine
|
|
ω-phonetoxin-IIA
|
|
Neurotoxin Tx3-4,
Omega-CNTX-Pn3a,
Omega-ctenitoxin-Pn3a,
ω-phonetoxin-2A,
ω-Ptx-IIA,
PF3,
Phoneutriatoxin 3-4,
Pn3-4A
|
|
[(3-Ph-Pr6), His7,D-Ala11,D-Pro13,ψ13-14),Phe14]bombesin-(6-14)
|
|
|
|
phrixotoxin 1
|
|
PaTX 1
|
|
phrixotoxin 2
|
|
κ-theraphotoxin-Ps1b,
κ-TRTX-Ps1b,
PaTX2,
PaTX 2,
Phrixotoxin-2
|
|
phyllomedusin
|
|
|
|
physalaemin
|
|
|
|
PL017
|
|
(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[(2R)-2-carbamoylpyrrolidin-1-yl]-1-oxo-3-phenyl-propan-2-yl]-N-methyl-pyrrolidine-2-carboxamide,
3-N-Me-Phe-morphiceptin,
PL 017
|
[3H]PL017
|
|
[3H]-PL017
|
|
PMX205
|
|
PMX 205
|
|
PMX53
|
|
PMX-53
|
|
ω-PnTx3-3
|
|
Neurotoxin Tx3-3,
ω-CNTX-Pn2a,
ω-ctenitoxin-Pn2a,
PnTx3-3
|
|
PnTx-3-6
|
|
Neurotoxin Tx3-6,
ω-CNTX-Pn4a,
ω-ctenitoxin-Pn4a,
PhAlpha-1-beta,
PhAlpha-1-beta toxin
|
|
[PP1-17,Ala31,Aib32]NPY (human)
|
|
|
[125I][PP1-17,Ala31,Aib32]NPY (human)
|
|
|
|
PP-(13-36) (human)
|
|
human pancreatic polypeptide (13-36)
|
|
PP-(20-36) (human)
|
|
human pancreatic polypeptide (20-36)
|
|
PP-(2-36) (human)
|
|
human pancreatic polypeptide (2-36)
|
[125I]PP (human)
|
|
[125I]-pancreatic polypeptide,
[125I]-PP
|
|
PRL-2915
|
|
PRL 2915
|
|
PRL-2970
|
|
PRL 2970
|
|
[Pro3]GIP
|
|
[Pro3]gastric inhibitory polypeptide
|
|
prokineticin-2β
|
|
|
|
[Pro7]neurokinin B
|
|
|
|
[Pro34]NPY
|
|
|
|
[Pro34]PYY (human)
|
|
human [Pro34] peptide tyrosine tyrosine,
human [Pro34] peptide YY
|
|
[Pro9]SP
|
|
[Pro9]substance P
|
[125I]PrRP31
|
|
[125I]-PrRP31
|
|
PrRP-(24-31) (human)
|
|
human prolactin-releasing peptide-24-31
|
[125I]PrRP-20 (human)
|
|
[125I]prolactin-releasing peptide-20
|
|
psalmotoxin 1
|
|
PcTx1
|
[125I]psalmotoxin 1
|
|
[125I]-PcTx1
|
|
pseudechetoxin
|
|
|
|
PTH-(1-34) (human)
|
|
|
|
PTH-(1-34) (rat)
|
|
|
|
PTHrP-(1-34)
|
|
parathyroid hormone-related peptide
|
|
PTHrP-(7-34) (human, rat, mouse)
|
|
parathyroid hormone related peptide 7-34
|
|
PTHrP-(1-21)/PTH-(22-34) (human)
|
|
hybrid of human PTHrP and human PTH
|
|
PTHrP-(1-20)/TIP-(23-39) (human)
|
|
|
[125I](Pyr1)apelin-13
|
|
|
[3H](Pyr1)[Met(0)11]-apelin-13
|
|
|
[125I]PYY
|
|
[125I]peptide tyrosine tyrosine,
[125I]peptide YY
|
[125I]PYY-(3-36) (human)
|
|
[125I]-peptide YY(3-36),
[125I]-PYY(3-36)
|
|
PYY-(13-36) (mouse, rat, pig)
|
|
porcine peptide tyrosine tyrosine (13-36),
porcine peptide YY (13-36),
rat peptide tyrosine tyrosine (13-36),
rat peptide YY (13-36)
|
|
PYY-(3-36) (pig)
|
|
porcine peptide tyrosine tyrosine (3-36),
porcine peptide YY (3-36)
|
[125I]PYY (pig)
|
|
[125I]pPYY
|
| |
| Q |
Back to top |
[125I]QRFP (human)
|
|
|